Search

everythingexperts & clinicslearnresearchcommunity

for

Search:↓

A 50 mg daily dose of ritlecitinib is effective for alopecia areata, with temporary treatment breaks up to 6 weeks not affecting results.

Tofacitinib effectively regrew scalp hair in an 11-year-old girl with alopecia areata.

Ritlecitinib helps regrow hair in people with alopecia totalis and universalis and is safe to use.

Steroid sulfatase inhibitors could help treat hormone-related disorders and cancers.

Eculizumab helps reduce blood transfusions and stabilize hemoglobin but increases infection risk and is expensive.

Baricitinib combined with other immune therapies may safely and effectively treat severe scalp hair loss.

Combining ATRA with TPO-RA effectively stabilizes platelet counts in ITP patients.

Ritlecitinib reduces alopecia areata symptoms by blocking JAK3/TEC signaling and T-cell activity.

Belimumab reduces disease activity, steroid use, and flares in lupus patients.

Topical squaric acid dibutylester worsened discoid lupus erythematosus in a patient.

A girl with Evans' syndrome had her low platelet count successfully treated with zanubrutinib.

Anti-IL-12/IL-23 antibody therapy effectively treats psoriasiform skin lesions in IBD patients.

New psoriasis treatments are effective but come with side effects and risks.

The treatment was effective for lupus nephritis with manageable side effects.

A man with vitiligo and alopecia saw quick skin and hair improvement with ruxolitinib, but skin color gains were lost after stopping treatment.

MC-DNA vector-based gene therapy can temporarily treat CBS deficiency in mice.

A severe medication reaction required long treatment and led to hair loss and thyroid issues.

Unorthodox dosing of tofacitinib and baricitinib is safe but less effective than standard dosing for treating alopecia areata in kids.

Cyclosporine cleared a woman's resistant skin condition quickly and kept it away for over a year.

Squaric acid dibutylester can cause severe skin reactions in people with allergies.

Daily subcutaneous testosterone effectively restores testosterone levels in men.

These new skin treatments are safer and more effective with minimal side effects.

Frequent blood transfusions in beta thalassemia can lead to thyroid problems.

Tildrakizumab showed limited effectiveness in treating chronic alopecia areata in a small group of patients.

Clofazimine effectively treated ashy dermatosis in a patient.

Ritlecitinib is effective and safe for treating severe alopecia areata in people aged 12 and older.

Lenalidomide effectively and safely treats skin symptoms in pediatric lupus, reducing the need for prednisone.